Related Experiment Videos
Drug Promotion in India Since 2000: Problems Remain.
Joel Lexchin1,2,3
1School of Health Policy and Management, York University, Toronto, Ontario, Canada.
Summary
This study analyzes pharmaceutical promotion in India, evaluating drug value, promotional tactics, and regulatory oversight. It highlights concerns regarding marketing practices and their impact on healthcare professionals and patient outcomes.
Area of Science:
- Pharmaceutical Marketing and Regulation
- Public Health in India
Background:
- Pharmaceutical companies extensively promote products globally, including in India.
- The ethical appropriateness of drug promotion hinges on the therapeutic value and benefit-to-harm ratio of medications.
Purpose of the Study:
- To analyze the therapeutic value of drugs marketed in India.
- To examine specific drug promotion strategies and their impact.
- To critique the regulatory framework governing pharmaceutical promotion in India.
Main Methods:
- Analysis of therapeutic value of Indian market medications.
- Examination of two Indian case studies on drug promotion.
- Description of promotional methods: journal ads, sales representatives, and educational events.
- Assessment of medical students', trainees', and doctors' exposure and attitudes towards promotion.
- Evaluation of promotion's influence on prescribing patterns.
Main Results:
- Drug promotion in India involves diverse tactics, including journal advertisements, sales representatives, and educational events.
- Exposure to pharmaceutical promotion influences the attitudes and prescribing behaviors of healthcare professionals.
- Existing regulatory frameworks for pharmaceutical promotion in India are deemed inadequate.
Conclusions:
- Critique of current industry, professional, and government regulations for pharmaceutical promotion in India.
- Need for enhanced oversight to ensure ethical marketing and protect public health.
- The therapeutic value of drugs must be established before promotion to ensure patient safety.